Otelixizumab
id:
otelixizumab-317-7221391
title:
Otelixizumab
text:
Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Otelixizumab
date created:
date modified:
2023-12-27T06:13:50Z
main entity:
{"identifier":"Q7108506","url":"https://www.wikidata.org/entity/Q7108506"}
image:
fields total:
13
integrity:
14